Z8 OCT-controlled 2D vs 3D LASIK
Precision of 2D vs 3D Low Energy Femto-LASIK: Intraoperative and Postoperative OCT-based Study
1 other identifier
interventional
13
1 country
1
Brief Summary
The aim of this study was to test the hypothesis that OCT-guided 110 µm targeted flaps will result in accurate, predictable, and precise thickness flaps, with low complication rates when performed and compared using both 2D and 3D flap geometry applications and how it correlated to visual experience and quality of life responses during the early postoperative period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2020
CompletedFirst Submitted
Initial submission to the registry
June 3, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedJune 11, 2020
June 1, 2020
5 months
June 3, 2020
June 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Predictability of central flap thickness in OCT-controlled 110 µm LASIK
Analyze central flap thickness in OCT-controlled 110 µm LASIK and to report on intended versus achieved flap thickness of one group with a 2D flap geometry in one eye and another group with a 3D flap geometry in the contralateral eye. All OCT measurements will be done in micron metres (µm).
1 month postoperatively
Secondary Outcomes (7)
Comparison of intraoperative flap thickness with pre- and postoperative results
1 week, 1 month
Postoperative planarity
1 week, 1 month
Intraoperative flap morphology
During surgery
Postoperative flap properties
1 week, 1 month
Visual outcomes
1 day, 1 week, 1 month
- +2 more secondary outcomes
Study Arms (2)
2D LASIK
EXPERIMENTALWith the 2D method, the flap resection is created in a planar mode (xy-plane), without vertical cut, at the requested depth.
3D LASIK
EXPERIMENTALWith the 3D method, the flap resection is done in a three-dimensional mode, at the requested depth, with the requested diameter and the desired border (side cut) angle
Interventions
2D and 3D cutting methods were randomly used in same subjects
Eligibility Criteria
You may qualify if:
- The recommended range of application for the correction of myopia is up to -8.00 D and for the correction of astigmatism up to 5.00 D.
- The limited for LASIK correction of myopia is up to -10.00 D and correction of astigmatism up to 6.00 D. If myopic astigmatism is to be corrected, the values for myopia and astigmatism must be added together.
- The recommended range for correction of hyperopia is up to 3.00 D. Up to 4.00 D is the range of limited application for hyperopia.
- Age ≥18 years with stable eyesight for over 12 months.
You may not qualify if:
- preoperative corneal thickness less than 480 μm
- predicted stromal thickness under the flap after ablation of less than 250 μm
- chronic progressive corneal disease and forme fruste keratoconus
- surgery before the age of 18 years
- symptomatic cataract
- Glaucoma with a marked loss of visual field
- Exudative macular degeneration.
- Concurrent participation in another ophthalmological clinical study
- Undergone former eye surgery
- Contact lens wear within the two weeks prior to commencement of preoperative measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zentrumsehstärke
Hamburg, 20251, Germany
Related Publications (7)
Huhtala A, Pietila J, Makinen P, Uusitalo H. Femtosecond lasers for laser in situ keratomileusis: a systematic review and meta-analysis. Clin Ophthalmol. 2016 Mar 7;10:393-404. doi: 10.2147/OPTH.S99394. eCollection 2016.
PMID: 27022236BACKGROUNDEldaly ZH, Abdelsalam MA, Hussein MS, Nassr MA. Comparison of Laser In Situ Keratomileusis Flap Morphology and Predictability by WaveLight FS200 Femtosecond Laser and Moria Microkeratome: An Anterior Segment Optical Coherence Tomography Study. Korean J Ophthalmol. 2019 Apr;33(2):113-121. doi: 10.3341/kjo.2018.0035.
PMID: 30977320BACKGROUNDPajic B, Vastardis I, Pajic-Eggspuehler B, Gatzioufas Z, Hafezi F. Femtosecond laser versus mechanical microkeratome-assisted flap creation for LASIK: a prospective, randomized, paired-eye study. Clin Ophthalmol. 2014 Sep 22;8:1883-9. doi: 10.2147/OPTH.S68124. eCollection 2014.
PMID: 25284975BACKGROUNDTomita M, Chiba A, Matsuda J, Nawa Y. Evaluation of LASIK treatment with the Femto LDV in patients with corneal opacity. J Refract Surg. 2012 Jan;28(1):25-30. doi: 10.3928/1081597X-20111213-01. Epub 2011 Dec 19.
PMID: 22185466BACKGROUNDPietila J, Huhtala A, Makinen P, Uusitalo H. Flap characteristics, predictability, and safety of the Ziemer FEMTO LDV femtosecond laser with the disposable suction ring for LASIK. Eye (Lond). 2014 Jan;28(1):66-71. doi: 10.1038/eye.2013.244. Epub 2013 Nov 15.
PMID: 24232315BACKGROUNDPietila J, Huhtala A, Makinen P, Salmenhaara K, Uusitalo H. Laser-assisted in situ keratomileusis flap creation with the three-dimensional, transportable Ziemer FEMTO LDV model Z6 I femtosecond laser. Acta Ophthalmol. 2014 Nov;92(7):650-5. doi: 10.1111/aos.12333. Epub 2013 Dec 26.
PMID: 24373615BACKGROUNDPorela-Tiihonen S, Kaarniranta K, Kokki M, Purhonen S, Kokki H. A prospective study on postoperative pain after cataract surgery. Clin Ophthalmol. 2013;7:1429-35. doi: 10.2147/OPTH.S47576. Epub 2013 Jul 15.
PMID: 23885165BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephan Linke, MD
Zentrumsehstarke Hamburg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 3, 2020
First Posted
June 11, 2020
Study Start
December 5, 2019
Primary Completion
April 23, 2020
Study Completion
April 23, 2020
Last Updated
June 11, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
It is not clear yet to what extend IPD will be implemented. Patient privacy and confidentiality are the most important factors to consider. We consider sharing limited information upon request.